Substance Use
Conditions
Brief summary
To test the effectiveness of a single 20-30 minute motivational interviewing-based brief intervention for substance use within HIV/AIDS settings.
Detailed description
The Substance Abuse Treatment to HIV care (SAT2HIV) project, a Type 2 Effectiveness-Implementation Hybrid Trial, seeks to address this gap in services by providing new knowledge regarding the effectiveness of brief intervention (BI) for substance use within community-based HIV/AIDS service settings, as well as new knowledge regarding how to address the well-documented underutilization of evidence-based practices in real-world settings. The specific aims of this project are: Aim 1: To experimentally test the effectiveness of a motivational interviewing-based BI for substance use within community-based HIV/AIDS service organizations, relative to usual care (UC). Aim 2: To experimentally test the effectiveness of adding an organizational-level implementation intervention called Implementation & Sustainment Facilitation (ISF) to enhance the effectiveness of the implementation strategy currently used by SAMHSA-funded Addiction Technology Treatment Centers (ATTCs; i.e., online introductory training, 2-day training workshop, ongoing feedback and coaching).
Interventions
BEHAVIORALMotivational Interviewing
Participants assigned to the experimental condition receive a single 20-30 minute motivational interviewing-based brief intervention for substance use.
Sponsors
National Institute on Drug Abuse (NIDA)
RTI International
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
Yes
Inclusion criteria
* Have HIV/AIDS. * Be 18 years of age or older. * Acknowledges use of at least one substance within the past 28 days and endorse 2+ substance use disorder symptoms during the past 12-months. * Provide signed and dated assurance of consent.
Exclusion criteria
* Are unable to speak English. * Are unwilling to allow brief intervention sessions to be audio recorded. * Are unwilling to participate in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ART Medication Adherence | 4 weeks post randomization | ART Medication Adherence - A continuous measure (ranges from 0 -28) that is based on a question that asks participants to report how many days during the past 28 days that they have missed at least one dose of their HIV medications. |
| Days of Primary Substance Use | 4 weeks post randomization | Days of Primary Substance Use - A continuous measure (ranges from 0 - 28) that is based on a question that asks participants to report how many days during the past 28 days they used their primary substance. |
| Number of Substance-related problems | 4 weeks post randomization | Number of Substance-related problems - A continuous measure (ranges from 0 - 11) that represents the sum of the number of 11 DSM-V substance use disorder symptoms participants report having occured during the past 28 days. |
| Times engaging in risky behaviors | 4 weeks post randomization | Times engaging in risky behaviors - A continuous measure (no specified range) that is based on a question that asks participants to report how many times during the past 28 days they engaged in unprotected sex, IV drug use, or needle sharing. |
| Days of Substance Use Treatment | 4 weeks post randomization | Days of Substance Use Treatment - A continuous measure (no specified range) that represents the sum of the number of days participants report going to residential treatment, outpatient treatment, or self-help group meetings during the past 28 days. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intentions to Change | 4 weeks post randomization | Intentions to Change - A continuous measure (ranges from 0 - 20) that represents the sum of two questions that ask participants to use a Likert-type scale where 0 equals Not at all and 10 equals The highest level possible to indicate their intentions during the past 4 weeks to a) reduce their use of their primary substance and b) completely stop using their primary substance. |
| Commitment to Change | 4 weeks post randomization | Commitment to Change - A continuous measure (ranges from 0 - 20) that represents the sum of two questions that ask participants to use a Likert-type scale where 0 equals Not at all and 10 equals The highest level possible to indicate their commitment during the past 4 weeks to a) reduce their use of their primary substance and b) completely stop using their primary substance. |
| Self-Efficacy to Change | 4 weeks post randomization | Self Efficacy for Change - A continuous measure (ranges from 0 - 20) that represents the sum of two questions that ask participants to use a Likert-type scale where 0 equals Not at all and 10 equals The highest level possible to indicate their confidence during the past 4 weeks to a) reduce their use of their primary substance and b) completely stop using their primary substance. |
| Urgency to Change | 4 weeks post randomization | Urgency to Change - A continuous measure (ranges from 0 - 20) that represents the sum of two questions that ask participants to use a Likert-type scale where 0 equals Not at all and 10 equals The highest level possible to indicate their urgency during the past 4 weeks to a) reduce their use of their primary substance and b) completely stop using their primary substance. |
Countries
United States
Outcome results
None listed